What Anpu Bio-Tech does

Anpu Bio-Tech (洛阳安普生物科技股份有限公司) is a Luoyang-based pharmaceutical and dermatological products manufacturer founded in 2006 and listed on China's NEEQ under neeq:839248. The company's core technology centres on coal tar formulations (notably 新择它煤焦油洗液 and 皮特莫司黑豆馏油软膏), traditional Chinese medicine integration, and multi-dosage-form manufacturing that spans washes, tablets, pills, oral liquids, capsules, granules, ointments, films and skincare products across nearly 100 SKUs and six sub-brands (奇诺滋, 盛唐新丹, 思瑞瑪, 芙莱美雅, 安普妥宁, 皮特莫司). Over 10 national patents and 30+ pipeline IP products support a position as standard-setter for medical coal tar washes in China, with clinical validation cited on more than 100,000 domestic patients.

The company makes money through four parallel streams: (1) branded dermatology and disinfection product sales at unit prices between RMB 48 and RMB 298 via a direct field sales force to private hospitals, clinics, chain pharmacies and third-terminal outlets; (2) franchise and distribution licensing through 皮科加盟 and 连锁加盟 programmes that grant exclusive territorial rights in exchange for partner commitments; (3) direct-to-consumer e-commerce through its Taobao enterprise store (anpubio.taobao.com) and the Alibaba 1688 wholesale platform (anpusw.1688.com); and (4) OEM and private-label (贴牌) manufacturing services for third-party skincare and disinfection brands, monetising its GMP-certified Luoyang facility. Revenue is concentrated in Central China, with no disclosed international footprint, no public revenue figures, and a recent strategic positioning towards medical-aesthetics adjacencies via the 2019 Chinese Clinical Medicine Association dermatology partnership.

Name

Anpu Bio-Tech

Legal name

洛阳安普生物科技股份有限公司

Website

http://www.anpusw.com/

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Anpu Bio-Tech is a Luoyang-based dermatological pharmaceutical manufacturer that produces coal tar washes, black soybean tar ointments, antibacterial washes, cosmeceuticals and health foods, selling via field sales to hospitals and pharmacies, regional franchise partners, Taobao and Alibaba 1688 e-commerce, and OEM/private-label services across China.

Ownership category

akta.pro rank

Product category

Dermatological Pharmaceuticals

NAICS

Toilet Preparation Manufacturing (325620), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Hand & Body Care (Lotions, Creams, Body Oils) (CRADANAC)

akta.pro secondary industry

Bath & Shower Products (Soaps, Body Wash, Bath Additives) (CRADANAB)

Keywords

• Dermatological medications
• Coal tar formulations
• Medicated skincare
• Pharmaceutical manufacturing
• OEM contract manufacturing

Headquarters

HQ city

Luoyang

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. Pharmaceutical and Skincare Product Sales: Company generates revenue primarily from manufacturing and selling dermatological products including disinfection products, healthcare products, cosmetics, diagnostic reagents, and vaccines. Products include 新择它抑菌洗液, 黑豆馏油抑菌软膏, 皮诺康复方煤焦油洗剂, and 芙莱美雅药妆 series.
2. Franchise and Distribution Licensing: Company recruits regional皮科加盟 (dermatology franchise) and 连锁加盟 (chain franchise) partners who pay for distribution rights and receive exclusive regional territory, product supply, marketing support, and market protection measures.
3. OEM/Contract Manufacturing: Company offers OEM and private label manufacturing services (贴牌) for disinfection and skincare products, allowing third parties to manufacture products under their own brands using Anpu's production facilities and formulations.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels5 records

Core offering

Anpu Bio-Tech (洛阳安普生物科技股份有限公司) develops, manufactures, and sells coal tar-based dermatological medications, including washes, ointments, sprays, creams, and gels, sold under multiple proprietary brands. The company also offers OEM/ODM contract manufacturing for skin care and personal care products, and operates regional franchise/distributor programs for its branded product lines.

Product overview

Anpu Bio-Tech is a high-tech enterprise focused on ecological Chinese medicinal herb cultivation, dermatological medications, health products, diagnostic reagents, and vaccine R&D and production. The company operates a diversified product portfolio spanning multiple sub-brands and product lines. The core products include the coal tar-based 新择它抑菌洗液 (established as China's standard for medical coal tar shampoos) and the 皮特莫司黑豆馏油软膏 (the company's flagship dermatological ointment). The skincare and health product lines include 奇诺滋 and 盛唐新丹 for health foods; 思瑞琪 and 芙莱美雅 for medicated cosmetics (药妆); and 安普妥宁 for external membrane products. The disinfection/product portfolio encompasses antibacterial washes, sprays, ointments, and creams under brands like 新泽康, 蓝泽康, 皮诺康, and 黑豆馏油. The company also offers OEM manufacturing and private label services. Production covers multiple dosage forms including lotions, tablets, pills, oral solutions, capsules, granules, ointments, films, and skincare products.

Differentiator

Problem solved

Functional benefit

Brands

• 奇诺滋: Health food (保健食品) product series.
• 盛唐新丹
• 皮特莫司
• 思瑞琪
• 芙莱美雅
• 安普妥宁

Products and services

• Coal Tar Dermatological Medications (New Zeta / Xinze It brand) Branded coal tar-based medicated wash products for skin conditions such as psoriasis, eczema, and seborrheic dermatitis, sold to medical institutions and through retail channels.
• Pitemoxi Black Bean Tar Ointment (皮特莫司黑豆馏油软膏) Coal tar/black bean distillate ointment for topical dermatological treatment, sold to hospitals, clinics, and pharmacies.
• Five Proprietary Brand Lines (奇诺滋, 盛唐新丹, 思瑞瑁, 芙莱美雅, 安普妥宁) A portfolio of five proprietary branded dermatological product lines covering medicated washes, ointments, sprays, creams, and skincare, sold through medical channels and retail.
• Xinze Kang Antibacterial Wash (新泽康抑菌洗液) Antibacterial wash liquid for skin hygiene and adjunct dermatological care.
• Lan Ze Kang Antibacterial Wash (蓝泽康抑菌洗液) Antibacterial wash liquid for skin hygiene and adjunct dermatological care.
• Pi Nuo Kang Compound Coal Tar Wash (皮诺康复方煤焦油洗剂) Compound coal tar medicated wash for scalp and skin conditions, sold through pharmacy and clinic channels.
• Pen Liu Weng Xin Antibacterial Spray (喷硫翁锌抑菌喷剂) Topical antibacterial spray for affected skin areas, providing adjunct treatment of skin infections.
• Shu Yin Ke Pen Liu Weng Xin Antibacterial Spray (舒银可喷硫翁锌抑菌喷剂) Topical antibacterial spray for affected skin areas, providing adjunct treatment of skin conditions.
• Fulaimeiya Ruili Qing Beauty Cream (芙莱美雅瑞丽清美颜霜) Beauty/skincare cream sold under the Fulaimeiya brand line for cosmetic and adjunct dermatological use.
• Allantoin Cream (尿囊素霜)
• Allantoin Vitamin E Antibacterial Cream (尿囊素维E抑菌乳膏) Allantoin combined with Vitamin E in an antibacterial cream base for skin repair, soothing, and moisturizing.
• OEM/ODM Contract Manufacturing Services OEM/ODM manufacturing services for skin care, personal care, and dermatological products, provided to brand owners and channel customers.
• Regional Franchise / Distributor Program Regional franchise/distributor licensing program for the company's branded product lines, providing regional partners authorization to sell the company's products in defined territories.

Quantifiable outcome

• 10余万例国内患者效果亲身验证
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• 中华临床医学会皮肤医美专业委员会 (Chinese Clinical Medicine Association - Dermatology and Aesthetic Medicine Professional Committee)coreStrategic or Co-development Partner · 22 April 2019In April 2019, Anpu became a strategic partner of the 中华临床医学会皮肤医美专业委员会. The partnership was announced at the committee's 2019 academic seminar. This partnership positions Anpu as a key player in dermatology and medical aesthetics, providing access to professional medical networks and academic resources.
• 北京手足病研究院 (Beijing Institute of Hand-Foot Disease)minorStrategic or Co-development Partner · 13 June 2017In June 2017, the Director of Beijing Institute of Hand-Foot Disease, along with executives from the National Foot Bath Association (全国足浴协会), visited Anpu's headquarters for inspection and cooperation discussions. They praised the company's products, production environment, and scale of operations.
• 河南科技大学 (Henan University of Science and Technology)coreStrategic or Co-development Partner · 1 January 2006Since 2006, Anpu has collaborated with Henan University of Science and Technology on the '安普生物人才计划项目' (Anpu Bio Talent Program). The program, initiated by Anpu's chairman Liu Zhipeng (who serves as a specially appointed medical professor at the university), provides advanced training courses for Anpu's R&D personnel. Courses are held on weekends and holidays at the university's medical research center, covering topics closely related to Anpu's professional domain. The program has enhanced the company's R&D capabilities and generated new scientific research achievements. The program has received direct attention from the Luoyang municipal government and established a model for university-enterprise resource cooperation.
• 济宁医学院 (Jining Medical University)minorOthersUniversity partnership logo displayed on company website, indicating collaborative relationship in education and research.
• 新乡医学院 (Xinxiang Medical University)minorOthersUniversity partnership logo displayed on company website, indicating collaborative relationship in education and research.
• 河南科技大学 (Henan University of Science and Technology)minorOthersUniversity partnership logo displayed on company website, indicating collaborative relationship in education and research.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• CR Sanjiu (华润三九): Major Chinese listed OTC pharmaceutical/TCM company with a broad consumer healthcare and dermatology portfolio; directly comparable in mixing branded TCM and chemical topicals through hospital, pharmacy, and franchise channels in China.
• Yunnan Baiyao Group (云南白药): Leading Chinese TCM pharma with consumer healthcare and topical product lines distributed through pharmacy and franchise channels; comparable in combining TCM heritage with branded OTC topical formulations.
• Mayinglong Pharmaceutical (马应龙药业): Chinese specialty pharma famous for its TCM topical ointments and dermatology-adjacent product portfolio; similar positioning in proprietary TCM topical formulations sold via pharmacy and OTC channels.
• Zhuhai Essex Bio-Pharmaceutical (珠海亿胜生物): Hong Kong-listed Chinese specialty bio-pharma focused on dermatology and ophthalmology topical biologics; closely comparable as a China-based dermatology-focused specialty pharma building branded topical franchises.
• Tongrentang (同仁堂): Historic Chinese TCM brand with broad dermatology and topical healthcare offerings; comparable in combining TCM heritage, GMP manufacturing, and pharmacy-driven distribution across China.

Broad incumbents

• Galderma: World's largest pure-play dermatology company with prescription and consumer skincare lines; a broad incumbent offering prescription and OTC dermatological topicals overlapping with Anpu's psoriasis/eczema/dermatitis treatment categories.
• La Roche-Posay (L'Oréal): Dermatological skincare brand from L'Oréal, sold through pharmacies and clinics globally; comparable as a broad incumbent in dermatology-grade skincare distributed via medical/OTC channels.
• LEO Pharma: Global dermatology specialist covering psoriasis, eczema, and skin infections; comparable as a broad incumbent in prescription and OTC coal-tar-adjacent topical treatments for chronic skin conditions.

Others

• Bayer Consumer Healthcare: Global OTC consumer health portfolio including dermatology and topical OTC products; adjacent comparable as a global consumer-health incumbent operating in dermatology categories relevant to Anpu.

Regional players

• Guilin Sanjin Pharmaceutical (桂林三金): Chinese-listed TCM pharma with branded topical and consumer healthcare lines; comparable as a Chinese specialty pharma distributing through hospital, pharmacy, and franchise channels within a similar domestic scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Anpu Bio-Tech